Valneva receives emergency use authorization from bahrain for its inactivated covid-19 vaccine vla2001

Saint herblain (france), march 1 , 2022 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced that the national health regulatory authority (nhra) of the kingdom of bahrain has granted emergency use authorization for valneva's inactivated, adjuvanted covid-19 vaccine, vla2001. this authorization follows a rolling review process with the bahraini nhra and reflects the nhra's initiative to support the authorization of covid-19 vaccines.
VALN Ratings Summary
VALN Quant Ranking